Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
featured
A Phase 2, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects with Age-Related Macular Degeneration with Geographic Atrophy (ReCLAIM-2)

The purpose of this study is to see how safe and effective the study drug elamipretide is for the treatment of Age-Related Macular Degeneration (AMD) with non-central Geographic Atrophy (GA) when taken every day for 48 weeks (about 11 months). The medication will be taken as a subcutaneous injection in …

The Retina Care Center
 (8.1 away) Contact site
  • 176 views
  • 23 Nov, 2020
  • +38 other locations
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole Based on Prior Endocrine Therapy in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3CA mutation with advanced breast cancer who have progressed on or after prior treatments

gonadotropin releasing hormone
cancer treatment
PIK3CA
immunostimulant
hormone therapy
Greater Baltimore Medical Center Cancer Center
 (7.6 away) Contact site
  • 506 views
  • 19 Aug, 2020
  • +118 other locations
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

This study is to assess the efficacy and safety of olaparib monotherapy versus olaparib in combination with an inhibitor of ATR (Ataxia-Telangiectasia Mutated (ATM) and Rad3-related protein kinase (Ceralasertib [AZD6738]) and olaparib monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib [AZD1775]) in second or third line setting …

Research Site
 (9.3 away) Contact site
  • 520 views
  • 29 Oct, 2020
  • +203 other locations
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression

psilocybin
Sheppard Pratt Health System
 (9.3 away) Contact site
  • 3258 views
  • 29 Nov, 2020
  • +22 other locations
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.

Johns Hopkins University School of Medicine
 (8.8 away) Contact site
  • 0 views
  • 29 Nov, 2020
  • +61 other locations
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Patients With Traumatic Brain Injury

This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).

University of Maryland Rehabilitation
 (7.1 away) Contact site
  • 3060 views
  • 29 Nov, 2020
  • +77 other locations
Evolocumab in Acute Coronary Syndrome

Vascular and myocardial inflammation are significantly increased in Acute Coronary Syndrome (ACS) patients, are closely correlated to LDL-C levels, and are associated with these adverse consequences in the post-ACS patient population. Serum proprotein convertase subtilisin/kerin type 9 (PCSK9) levels are also increased in ACS, may raise LDL-C, and the investigators' …

infarct
troponin
myocardial infarction
stemi
Steven Paul Schulman
 (3.0 away) Contact site
  • 1 views
  • 06 Jan, 2020
  • 1 location
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

This is a Phase 2, randomized, double-blind, placebo-controlled, 2-stage trial in subjects with squamous cell cancers of the mouth, oropharynx, hypopharynx and nasopharynx planned to receive standard fractionated IMRT-delivered radiotherapy with concomitant chemotherapy (cisplatin). Informed consent will be obtained from each subject prior to enrollment. The trial will be performed …

mucositis
carcinoma
squamous cell carcinoma
cancer
Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 17 views
  • 20 Jul, 2020
  • +21 other locations
A Study Assessing the Efficacy and Safety of CBP-201

This study will evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of CBP-201 in adult subjects with moderate to severe atopic dermatitis.

Connect Investigative Site 319
 (7.7 away) Contact site
  • 325 views
  • 11 Nov, 2020
  • +53 other locations
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder Including Suicidal Ideation in Pediatric Participants Assessed to be at Imminent Risk for Suicide

The purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of intranasal esketamine {28 milligram (mg), 56 mg, and 84 mg} compared with psychoactive placebo (oral midazolam) in rapidly reducing the symptoms of major depressive disorder (MDD) including suicidal ideation in …

suicide
psychiatric disorder
major depressive disorder
suicidal
depression
Sheppard Pratt Health System
 (9.3 away) Contact site
  • 1834 views
  • 22 Nov, 2020
  • +90 other locations